Vantive, formerly Baxter Kidney Care, launched as a new standalone organ therapy company following the completion of its acquisition by funds managed by global investment firm Carlyle from Baxter.
Baxter Kidney Care is now Vantive, a standalone organ therapy company
February 5, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Lumos advances FebriDx sales with iMedical purchase order
May 14, 2025 - - Australian Biotech -
New Liberal leader Sussan Ley was responsible for major PBS reforms
May 13, 2025 - - Latest News -
New administrative order confirms the total move of NDIS to health
May 13, 2025 - - Latest News -
Trump's language on pricing matches Australia's reflex response to PBS criticism
May 13, 2025 - - Latest News -
Health stakeholders welcome the reappointment of Mark Butler
May 12, 2025 - - Latest News -
Pharma stocks rise in response to Trump's 'MFN' executive order
May 12, 2025 - - Latest News -
Lilly touts weight management results in new head-to-head study
May 12, 2025 - - Latest News